White Paper

The Role Of The Technical Transfer Executive Sponsor

By Amy Trotch, Business Development Director, Societal CDMO


The global pharma industry is challenging and unpredictable and sourcing materials, securing domestic capacity, and navigating the complex regulatory landscape can leave sponsors vulnerable to risks. Leveraging the expertise and advanced technical capabilities of a CDMO is becoming increasingly important for sponsors aiming to accelerate their novel drug to market. Executing a successful technical transfer is a key element of partnering with a CDMO and can impact your ability to meet project milestones on time.

Successful technical transfer programs will depend heavily on the executive sponsor’s (ES) level of engagement with the program. They play a critical role in communicating the organization’s culture from the beginning of vendor selection activities and reiterate the strategic vision of the program as it progresses.

Building and maintaining a strong relationship with your ES is crucial as it will serve as the foundation for long-term commercial success. Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical and analytical capabilities, regulatory support, quality system, and audit inspection history as well as its executive sponsorship model.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online